功能化单壁碳纳米管作为合理设计的载体,用于瘤向药物输送
Jingyi Chen1, Shuyi Chen, Xianrui Zhao
1Condensed Matter Physics and Materials Science Department, Brookhaven National Laboratory, Upton, New York 11973, USA.
Journal of the American Chemical Society
|June 26, 2009
概括
一种基于单壁碳纳米管 (SWNT) 的新型药物输送系统 (DDS) 有效准瘤. 这种生物相容的DDS可以在癌细胞内释放抗癌药物,显示出高强度,为未来的发展奠定了坚实的基础.
科学领域:
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 开发有针对性的药物输送系统 (DDS) 对于提高癌症治疗疗效和减少副作用至关重要.
- 单壁碳纳米管 (SWNTs) 由于其独特的特性,为药物输送提供了一个有前途的生物相容平台.
- 目前的DDS往往缺乏特异性,导致非目标药物积累和毒性.
研究的目的:
- 开发和评估一种新的基于SWNT的DDS,用于针对性地将抗癌药物输送到瘤细胞.
- 研究药物释放机制和SWNT-DDS的细胞吸收.
- 评估SWNT-DDS对癌细胞系的特异性和细胞毒性.
主要方法:
- 功能化的SWNTs与瘤向模块 (生物素) 和前药物 (带有可切割链接器的taxoid) 相结合.
- 三个光和化分子探针被合成用于跟踪和分析.
- 使用共聚焦光显微镜研究L1210FR白血病细胞中受体介导的内细胞和药物释放.
- 细胞毒性和特异性通过将DDS与L1210和人类非癌细胞系进行比较来评估.
主要成果:
- 基于SWNT的DDS证明了瘤向和内部化成功进入癌细胞.
- 在瘤细胞内证实了局部药物激活和释放.
- DDS对向的癌细胞系表现出高特异性和强大的细胞毒性.
- 与非向方法相比,比较性研究显示效率提高,毒性降低.
结论:
- 开发的基于SWNT的DDS是针对性癌症治疗的有效平台.
- 该系统成功地在瘤细胞内分泌和释放抗癌药物.
- 这种新型的DDS显示出在瘤学领域进一步发展的巨大潜力.
- 这些发现为未来基于SWNT的药物输送临床应用提供了坚实的基础.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

